by Janet Maker, Ph.D. | Jan 18, 2021 | Chemotherapy, News
Unless you cause the cancer stem cell to differentiate back into a normal cell, no matter how much chemotherapy or radiation you do, no matter how much tumor shrinkage or cancer reduction you achieve, the cancer will return and be even more aggressive, growing faster....
by Janet Maker, Ph.D. | Jan 3, 2021 | Chemotherapy, News
A new drug delivery system, promises to deliver the chemo drug straight into tumors with fewer side effects. Source: This New Therapy Lessens the Side Effects of Chemo
by Janet Maker, Ph.D. | Dec 17, 2020 | Chemotherapy, News
Tel Aviv University team uses ‘microscopic scissors’ to pinpoint and eliminate cancerous cells; results of animal tests just published, trial in humans expected within 2 years Source: With new ‘elegant chemo,’ Israeli scientists edit genome to destroy...
by Janet Maker, Ph.D. | Nov 18, 2020 | Chemotherapy, News
Cancer might be better controlled by administering low-doses of chemotherapy drugs rather than using toxically high doses that damage the body but still allow drug-resistant tumour cells to spread, a study has suggested. Source: Cancer: Low doses of chemotherapy...
by Janet Maker, Ph.D. | Sep 11, 2020 | Chemotherapy, News
There are different types of ports, and Christina went with a power port. Source: Breast Cancer Survivor Talks About Her Personal Experience With A Chemo Port Implant | The Breast Cancer Site Blog
by Janet Maker, Ph.D. | Aug 17, 2020 | Chemotherapy, News
No matter how many pamphlets a patient reads or documents someone peruses, those items rarely tell the whole story. Here are five things medical professionals might not tell a cancer patient. Source: 5 Things People Never Tell You About Chemo | The Breast Cancer Site...
by Janet Maker, Ph.D. | Apr 10, 2020 | Chemotherapy, News
In this video, oncologist Melissa Wilson, MD, PhD, explains how the new, FDA-approved immunotherapy attacks cancer cells differently than traditional chemotherapy. Source: How Is Immunotherapy Different from Chemotherapy? – HealthiNation
by Janet Maker, Ph.D. | Mar 16, 2020 | Chemotherapy, News
Researchers from Australia’s Flinders University say that as many as 25 percent of chemotherapy and radiotherapy patients develop heart failure as a result of their treatment. Perhaps even more concerningly, most of these patients have little to no knowledge of the...
by Janet Maker, Ph.D. | Mar 9, 2020 | Chemotherapy, News
The new study comes as alarming laboratory tests detected PFAS in tap water sampled across the country. Source: PFAS “Forever Chemicals” Found in Tap Water Linked to Cancer Risks
by Janet Maker, Ph.D. | Feb 18, 2020 | Chemotherapy, News
Israeli firm Alpha Tau Medical has developed a new cancer treatment that attacks tumors while sparing healthy tissue. The treatment is called Alpha DaRT (Diffusing Alpha-emitters Radiation Treatment), according to The Jerusalem Post. Source: New Israeli Cancer...
by Janet Maker, Ph.D. | Dec 30, 2019 | Chemotherapy, News
The following examples show overall survival rates for people with different types of cancer, along with the percentage of those receiving chemotherapy as part of their treatment. Source: Chemotherapy: Success rates for different cancers
by Janet Maker, Ph.D. | Dec 4, 2019 | Chemotherapy, News
Researchers from the Czech Republic hope this could be a ‘gentler’ form of chemo, with conventional treatments ‘poisoning’ cells and causing nasty side effects Source: Chemical found only in breast milk ‘breaks tumours into tiny...
by Janet Maker, Ph.D. | Sep 5, 2019 | Chemotherapy, News
Reducing the interval between chemotherapy treatment cycles or administering chemotherapy medications sequentially at higher doses, rather than simultaneously at lower doses, increases treatment efficacy and decreases the risk of breast cancer recurrence and death, a...
by Janet Maker, Ph.D. | Jul 27, 2019 | Chemotherapy, News
Mouth sores are common during cancer treatment. Get details on causes, prevention and treatment. Source: Mouth sores caused by cancer treatment: How to cope – Mayo Clinic
by Janet Maker, Ph.D. | Jul 19, 2019 | Chemotherapy, News
Rodent studies demonstrated that fasting prior to the administration of chemotherapy prolongs survival, decreases metastasis, and reduces toxicity. Source: Intermittent Fasting and Cancer – Cancer Therapy Advisor
by Janet Maker, Ph.D. | Jul 14, 2019 | Chemotherapy, News
An NIH study finds patients treated with chemotherapy for most solid tumors had an increased risk of tMDS/AML, a rare but often fatal type of leukemia. Source: Study finds higher risk of rare blood cancer after chemo – National Cancer Institute
by Janet Maker, Ph.D. | Jul 3, 2019 | Chemotherapy, News
An NIH study finds patients treated with chemotherapy for most solid tumors had an increased risk of tMDS/AML, a rare but often fatal type of leukemia. Source: Study finds higher risk of rare blood cancer after chemo – National Cancer Institute
by Janet Maker, Ph.D. | Jun 28, 2019 | Chemotherapy, News
C Patients older than age 65 with breast cancer are at an increased risk of developing toxicity associated with adjuvant chemotherapy. “We developed and validated a risk score that identifies an older patient’s risk for adjuvant breast cancer chemotherapy toxicity,”...
by Janet Maker, Ph.D. | Apr 27, 2019 | Chemotherapy, News
The results may herald a new era in which doctors make smarter decisions about how much is enough when treating different cancers. “This is the dawn of the de-escalation era,” says Hurvitz. “We need to move forward looking for ways to de-escalate therapy that is not...
by Janet Maker, Ph.D. | Mar 30, 2019 | Chemotherapy, News
Two recent studies detail a natural mechanism that, if harnessed properly, may be able to destroy cancer cells and their ability to become resistant to treatment — without any of the side effects of chemotherapy. Source: Nature’s ‘kill code’...